Alkermes and Cogent Biosciences Stock See Action From Activi

Sarissa Capital is pushing for change at biopharmaceutical firm Alkermes. Fairmount Funds lifted its investment in Cogent Biosciences.

Related Keywords

Edward Lampert , Janssen Pharmaceutica , Alkermes , Lampert Foundation , Exchange Commission , Atlas Venture Fund , Alkerme June , Value Enhancement Plan , Venture Fund , Viridian Therapeutics , Article Normal , Biotechnology Services , Pharmaceuticals , Healthcare Life Sciences , Biopharmaceuticals , Biological Therapy , Healthcare Provision , Management , Shareholder Activism , Corporate Industrial News , Corporate Governance , Environmental Social Governance , Content Types , Factiva Filters , C Amp Ampe Industry News Filter , Synd , 13d Filings , Activist Investing , Biotech And Pharma , Autos , Retail , Companies , Department , Magazine , Talks , Cogent Biosciences , Wcogt , Vrdn , Johnson Amp , Jnj , Autonation , Han , Corporate , Industrial News , Environmental , Social , Governance , Healthcare , Life Sciences ,